NO20033911D0 - Somatostatin antagonister - Google Patents
Somatostatin antagonisterInfo
- Publication number
- NO20033911D0 NO20033911D0 NO20033911A NO20033911A NO20033911D0 NO 20033911 D0 NO20033911 D0 NO 20033911D0 NO 20033911 A NO20033911 A NO 20033911A NO 20033911 A NO20033911 A NO 20033911A NO 20033911 D0 NO20033911 D0 NO 20033911D0
- Authority
- NO
- Norway
- Prior art keywords
- somatostatin antagonists
- somatostatin
- antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27430801P | 2001-03-08 | 2001-03-08 | |
PCT/US2002/006676 WO2002072602A2 (en) | 2001-03-08 | 2002-03-05 | Somatostatin antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20033911D0 true NO20033911D0 (no) | 2003-09-04 |
NO20033911L NO20033911L (no) | 2003-10-29 |
Family
ID=23047655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20033911A NO20033911L (no) | 2001-03-08 | 2003-09-04 | Somatostatin antagonister |
Country Status (16)
Country | Link |
---|---|
US (3) | US7378488B2 (no) |
EP (1) | EP1372688B1 (no) |
JP (3) | JP4204322B2 (no) |
AR (1) | AR035942A1 (no) |
AT (1) | ATE394114T1 (no) |
AU (1) | AU2002258465B2 (no) |
CA (1) | CA2439498A1 (no) |
CZ (1) | CZ299362B6 (no) |
DE (1) | DE60226419D1 (no) |
DK (1) | DK1372688T3 (no) |
ES (1) | ES2306766T3 (no) |
HU (1) | HUP0401535A3 (no) |
NO (1) | NO20033911L (no) |
PL (1) | PL362838A1 (no) |
RU (2) | RU2328504C2 (no) |
WO (1) | WO2002072602A2 (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100707408B1 (ko) * | 2000-10-20 | 2007-04-13 | 더 어드미니스트레이터즈 오브 더 튜래인 어듀케이셔널 훤드 | 유로텐신-ⅱ 작용제 및 길항제 |
CA2439498A1 (en) | 2001-03-08 | 2002-09-19 | The Administrators Of The Tulane Educational Fund | Somatostatin antagonists |
HUP0303727A2 (hu) * | 2001-04-09 | 2004-03-01 | The Administrators Of The Tulane Educational Fund | Szomatosztatin agonisták és ezek alkalmazása |
EP1522311A1 (fr) | 2003-10-10 | 2005-04-13 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Utilisation de la somatostine ou d'un de ses analogues pour préparer un médicament destiné à réguler la réserve folliculaire ovarienne chez la femme non ménopausée |
WO2006063465A1 (en) * | 2004-12-15 | 2006-06-22 | Diamedica Inc. | Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists |
US8691761B2 (en) | 2006-10-16 | 2014-04-08 | Jean E. F. Rivier | Somatostatin receptor 2 antagonists |
PL2076535T3 (pl) * | 2006-10-16 | 2013-08-30 | Salk Inst Biological Studies | Antagoniści somatostatyny selektywni względem receptora (SSTR2) |
EP2168983A1 (fr) | 2008-09-30 | 2010-03-31 | Ipsen Pharma | Nouveaux composés octapeptidiques et leur utilisation thérapeutique |
EP2351848B1 (en) * | 2008-10-29 | 2018-02-28 | Kaneka Corporation | Method for producing l-amino acid |
EP2399931A1 (fr) * | 2010-06-22 | 2011-12-28 | Ipsen Pharma S.A.S. | Nouveaux composés octapeptidiques et leur utilisation thérapeutique |
KR20180117636A (ko) | 2016-02-09 | 2018-10-29 | 씨디알디 벤쳐스 인코포레이티드 | 소마토스타틴 수용체 길항제 화합물 및 이의 이용 방법 |
WO2021111503A1 (ja) * | 2019-12-02 | 2021-06-10 | 花王株式会社 | 光吸収層及びその製造方法、分散液、光電変換素子、並びに太陽電池 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0098457B1 (en) * | 1980-02-14 | 1987-08-05 | Sandoz Ag | (1s,2r,3r)- and (1r,2s,3s)-nitrilo-1-carbonyl-3-methyl-2-oxy-heptanes and -hept-5-enes useful in the total synthesis of cyclosporins and processes for their production |
JPS63146850A (ja) | 1986-11-12 | 1988-06-18 | メルク エンド カムパニー インコーポレーテツド | フエニルアラニル−ヒスチジン代用成分を有するレニン阻害剤 |
EP0278158A3 (en) | 1986-11-12 | 1990-05-23 | Merck & Co. Inc. | Renin inhibitors containing phenylalanyl-histidine replacements |
EP0273696A2 (en) | 1987-01-02 | 1988-07-06 | Merck & Co. Inc. | Renin inhibitors containing histidine replacements |
CH679045A5 (no) | 1987-06-29 | 1991-12-13 | Sandoz Ag | |
JPS6426599U (no) | 1987-08-10 | 1989-02-15 | ||
EP0328090A3 (en) | 1988-02-10 | 1990-08-16 | Abbott Laboratories | Lhrh analogs |
DK0457888T3 (da) * | 1989-12-08 | 1996-08-12 | Univ Tulane | Octapeptidanaloger af somatostatin med threonin i 6-stillingen |
US7223833B1 (en) * | 1991-05-24 | 2007-05-29 | Isis Pharmaceuticals, Inc. | Peptide nucleic acid conjugates |
EP0592512A1 (en) | 1991-07-01 | 1994-04-20 | University Technologies International Inc. (Uti) | NON-DESENSITIZING ANALOGS OF GnRH AND OTHER BIOLOGICALLY ACTIVE LIGANDS |
JP3480848B2 (ja) * | 1992-06-19 | 2003-12-22 | タカラバイオ株式会社 | 環状ペプチドの合成方法 |
US5569741A (en) * | 1992-07-27 | 1996-10-29 | Biomeasure, Inc. | Cyclic octapeptide neuromedin B receptor antagonists |
ATE284413T1 (de) * | 1993-08-09 | 2004-12-15 | Sod Conseils Rech Applic | Therapeutische peptid derivate |
GB9402767D0 (en) | 1994-02-14 | 1994-04-06 | Sandoz Ltd | Improvements in or relating to organic compounds |
US5696230A (en) * | 1994-08-31 | 1997-12-09 | The Board Of Regents Of The University Of Nebraska | High-affinity response-selective C-terminal analogs of C5a anaphylatoxin |
US5750499A (en) * | 1995-10-18 | 1998-05-12 | The Salk Institute For Biological Studies | Receptor-selective somatostatin analogs |
US5846934A (en) * | 1996-02-20 | 1998-12-08 | American Cyanamid Company | Pure somatostatin antagonist and methods of use thereof |
US6355613B1 (en) * | 1996-07-31 | 2002-03-12 | Peptor Limited | Conformationally constrained backbone cyclized somatostatin analogs |
WO1998008528A1 (en) | 1996-08-30 | 1998-03-05 | Biomeasure Incorporated | Method of inhibiting fibrosis with a somatostatin agonist |
AU4133997A (en) * | 1996-09-12 | 1998-04-02 | Yarom Cohen | Pharmaceutical composition for the treatment of syndrome x of reaven |
KR100479149B1 (ko) | 1996-12-04 | 2005-03-25 | 더 어드미니스트레이터즈 오브 더 튜래인 어듀케이셔널 훤드 | 소마토스타틴 길항제 |
US6887470B1 (en) * | 1999-09-10 | 2005-05-03 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
DE60220157T2 (de) * | 2001-03-06 | 2008-01-17 | Il Consorzio Ferrara Richerche | Verfahren zur modulierung der proliferation von medullären schilddrüsen-karzinomzellen |
CA2439498A1 (en) | 2001-03-08 | 2002-09-19 | The Administrators Of The Tulane Educational Fund | Somatostatin antagonists |
HUP0303727A2 (hu) | 2001-04-09 | 2004-03-01 | The Administrators Of The Tulane Educational Fund | Szomatosztatin agonisták és ezek alkalmazása |
-
2002
- 2002-03-05 CA CA002439498A patent/CA2439498A1/en not_active Abandoned
- 2002-03-05 PL PL02362838A patent/PL362838A1/xx not_active Application Discontinuation
- 2002-03-05 DE DE60226419T patent/DE60226419D1/de not_active Expired - Lifetime
- 2002-03-05 RU RU2005117614/04A patent/RU2328504C2/ru not_active IP Right Cessation
- 2002-03-05 DK DK02728410T patent/DK1372688T3/da active
- 2002-03-05 US US10/469,836 patent/US7378488B2/en not_active Expired - Lifetime
- 2002-03-05 EP EP02728410A patent/EP1372688B1/en not_active Expired - Lifetime
- 2002-03-05 RU RU2003129807/04A patent/RU2263678C2/ru not_active IP Right Cessation
- 2002-03-05 ES ES02728410T patent/ES2306766T3/es not_active Expired - Lifetime
- 2002-03-05 JP JP2002571515A patent/JP4204322B2/ja not_active Expired - Fee Related
- 2002-03-05 WO PCT/US2002/006676 patent/WO2002072602A2/en active IP Right Grant
- 2002-03-05 AU AU2002258465A patent/AU2002258465B2/en not_active Ceased
- 2002-03-05 HU HU0401535A patent/HUP0401535A3/hu unknown
- 2002-03-05 AT AT02728410T patent/ATE394114T1/de not_active IP Right Cessation
- 2002-03-05 CZ CZ20032281A patent/CZ299362B6/cs not_active IP Right Cessation
- 2002-03-07 AR ARP020100831A patent/AR035942A1/es not_active Application Discontinuation
-
2003
- 2003-09-04 NO NO20033911A patent/NO20033911L/no not_active Application Discontinuation
-
2006
- 2006-07-05 JP JP2006185373A patent/JP2006342171A/ja active Pending
-
2007
- 2007-08-20 US US11/894,231 patent/US7408024B2/en not_active Expired - Lifetime
-
2008
- 2008-03-11 US US12/075,319 patent/US20080171853A1/en not_active Abandoned
- 2008-05-12 JP JP2008124961A patent/JP2008255120A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2306766T3 (es) | 2008-11-16 |
WO2002072602A2 (en) | 2002-09-19 |
US7408024B2 (en) | 2008-08-05 |
NO20033911L (no) | 2003-10-29 |
US20080171853A1 (en) | 2008-07-17 |
CZ20032281A3 (cs) | 2004-01-14 |
DK1372688T3 (da) | 2008-08-25 |
US7378488B2 (en) | 2008-05-27 |
RU2263678C2 (ru) | 2005-11-10 |
HUP0401535A3 (en) | 2009-07-28 |
RU2005117614A (ru) | 2006-11-20 |
JP2008255120A (ja) | 2008-10-23 |
PL362838A1 (en) | 2004-11-02 |
US20040181032A1 (en) | 2004-09-16 |
JP4204322B2 (ja) | 2009-01-07 |
CZ299362B6 (cs) | 2008-07-02 |
EP1372688A4 (en) | 2006-06-14 |
EP1372688A2 (en) | 2004-01-02 |
HUP0401535A2 (hu) | 2004-12-28 |
WO2002072602A3 (en) | 2003-03-20 |
AR035942A1 (es) | 2004-07-28 |
RU2003129807A (ru) | 2005-03-20 |
JP2004532824A (ja) | 2004-10-28 |
AU2002258465B2 (en) | 2006-01-19 |
ATE394114T1 (de) | 2008-05-15 |
CA2439498A1 (en) | 2002-09-19 |
EP1372688B1 (en) | 2008-05-07 |
RU2328504C2 (ru) | 2008-07-10 |
US20080020970A1 (en) | 2008-01-24 |
JP2006342171A (ja) | 2006-12-21 |
DE60226419D1 (de) | 2008-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE402148T1 (de) | Substituierte pyridinylamine | |
IS7016A (is) | Ný 4-anilínókínólín-3-karboxamíð | |
ATE524462T1 (de) | C5-modifizierte indazolylpyrrolotriazine | |
DE50206892D1 (de) | Substituierte imidazotriazinone | |
ATE335486T1 (de) | Hydrazono-malonitrile | |
DE1319930T1 (de) | Coriolismassendurchflussmesser | |
NO20034497D0 (no) | Somatostatin agonister | |
NO20014597D0 (no) | Fremgangsmåte | |
DE60222693D1 (de) | Nk1-antagonisten | |
DK1373228T3 (da) | Substituerede fluoralkoxyphenylsulfonylurinstoffer | |
ATE394114T1 (de) | Somatostatin-antagonisten | |
ATE355059T1 (de) | Isoxazolopyridinone | |
DK1406858T3 (da) | Substituerede 4-aminocyklohexanoler | |
DE50214673D1 (de) | Schnittstelle | |
DE50212426D1 (de) | Bohrwerkzeug | |
ATE319694T1 (de) | Phenylalkyne | |
ATA18372001A (de) | Gelenksbolzenbaueinheit | |
DE10295006D2 (de) | Bauwerksabdichtung | |
ATA13992002A (de) | Schlackengranulierungsanlage | |
DE60216967D1 (de) | Substituierte cyclohexanderivate | |
ATE405973T1 (de) | Steckverbindung | |
ATA2892002A (de) | Beschlag | |
AT500276B8 (de) | Radschwenksystem | |
ATA7462001A (de) | Radspannwerk | |
DE10196706D2 (de) | Nagelfeile |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |